Physician profile
Amber Walker
NPI 1891337614
$465.92
in general payments reported to CMS, 2019-2025
12 companies · $205 in 2025
The $205 reported for 2025 was more than what 75% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $61.30 · 2022: $128 · 2023: $72.10 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $276.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $133.68 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $72.31 | 2025 | Jornay Pm |
| Sanofi Pasteur INC. | $51.29 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $43.56 | 2021-2022 | |
| Mylan Specialty L.P. | $27.86 | 2023 | Yupelri |
| Abbvie INC. | $27.82 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.04 | 2021 | |
| Tris Pharma INC | $18.94 | 2025 | Dyanavel Xr |
| Ars Pharmaceuticals Operations, INC. | $18.88 | 2025 | Neffy |
| Seqirus USA INC | $18.17 | 2025 | Flucelvax |
| Adlon Therapeutics L.P. | $15.40 | 2021 | |
| Sobi, INC | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.